GlaxoSmithKline Pharmaceuticals today reported a 5.09 per cent decline in its net profit at Rs 93.28 crore for the first quarter ended June 30, hit by supply constraints.
The company had posted a net profit of Rs 98.29 crore for the same period of the previous fiscal.
Net sales the company also declined to Rs 621.85 crore for the first quarter, as compared to Rs 654.96 crore in the same period of the previous financial year, GlaxoSmithKline Pharmaceuticals said in a filing to the BSE.
“The quarterly performance was impacted by supply constraints,” it added.
The company’s stock was trading at Rs 3,482.35, down 1.20 per cent, on the BSE.